NM_000251.3:c.1680T>C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The NM_000251.3(MSH2):​c.1680T>C​(p.Asn560Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000359 in 1,540,646 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★★).

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00035 ( 1 hom. )

Consequence

MSH2
NM_000251.3 synonymous

Scores

2

Clinical Significance

Likely benign reviewed by expert panel U:1B:21

Conservation

PhyloP100: 0.581

Publications

5 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 2-47470983-T-C is Benign according to our data. Variant chr2-47470983-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 90744.Status of the report is reviewed_by_expert_panel, 3 stars.
BP7
Synonymous conserved (PhyloP=0.581 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.1680T>Cp.Asn560Asn
synonymous
Exon 11 of 16NP_000242.1P43246-1
MSH2
NM_001406674.1
c.1680T>Cp.Asn560Asn
synonymous
Exon 11 of 18NP_001393603.1
MSH2
NM_001406631.1
c.1680T>Cp.Asn560Asn
synonymous
Exon 11 of 18NP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.1680T>Cp.Asn560Asn
synonymous
Exon 11 of 16ENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.1680T>Cp.Asn560Asn
synonymous
Exon 11 of 16ENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.1731T>Cp.Asn577Asn
synonymous
Exon 12 of 17ENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.000407
AC:
62
AN:
152170
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000617
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000284
AC:
71
AN:
250078
AF XY:
0.000303
show subpopulations
Gnomad AFR exome
AF:
0.0000622
Gnomad AMR exome
AF:
0.0000581
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.000557
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000354
AC:
491
AN:
1388476
Hom.:
1
Cov.:
23
AF XY:
0.000327
AC XY:
227
AN XY:
695002
show subpopulations
African (AFR)
AF:
0.0000312
AC:
1
AN:
32082
American (AMR)
AF:
0.0000673
AC:
3
AN:
44552
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25682
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39258
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84348
European-Finnish (FIN)
AF:
0.000244
AC:
13
AN:
53330
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5388
European-Non Finnish (NFE)
AF:
0.000439
AC:
459
AN:
1046054
Other (OTH)
AF:
0.000260
AC:
15
AN:
57782
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000407
AC:
62
AN:
152170
Hom.:
0
Cov.:
32
AF XY:
0.000363
AC XY:
27
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41432
American (AMR)
AF:
0.000131
AC:
2
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000617
AC:
42
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000443
Hom.:
0
Bravo
AF:
0.000412
EpiCase
AF:
0.000273
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
4
not specified (4)
-
1
2
Lynch syndrome 1 (3)
-
-
2
Lynch syndrome (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
Malignant tumor of breast (1)
-
-
1
Muir-Torré syndrome;C2936783:Lynch syndrome 1;C5436806:Mismatch repair cancer syndrome 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
4.3
DANN
Benign
0.55
PhyloP100
0.58
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200056411; hg19: chr2-47698122; API